Get Your Personalized Supplement StackSupplement Stack Quiz

Ruscogenins

Also known as: Ruscogenin, Neoruscogenin, Ruscus aculeatus, Butcher's Broom, Ruscogenins

Overview

Ruscogenins are a class of steroidal saponins primarily derived from the plant *Ruscus aculeatus*, also known as Butcher's Broom. These compounds are traditionally utilized for their vasoprotective and anti-inflammatory properties. Ruscogenins are commonly used in clinical settings to treat conditions such as hemorrhoidal disease, varicose veins, and venous insufficiencies. They exhibit significant pharmacological actions including anti-inflammatory, antithrombotic, and antielastase effects. The research on ruscogenins shows moderate maturity with several randomized controlled trials and meta-analyses supporting their efficacy, particularly in improving symptoms associated with hemorrhoidal disease. As part of the phlebotonics category, they aim to enhance venous tone, reduce venous insufficiency symptoms, and exhibit favorable safety profiles when used as directed.

Benefits

Ruscogenins, particularly in combination with other phlebotonics like diosmin and hesperidin, have shown significant efficacy in the treatment of hemorrhoidal disease. A pivotal study demonstrated that a combination of ruscogenin (100 mg), diosmin (500 mg), and hesperidin (90 mg) over 30 days resulted in marked improvements in symptoms such as bleeding, pain, and soiling in patients suffering from Grades II, III, and IV hemorrhoids. The positive effects extend to their anti-inflammatory and antithrombotic properties, benefiting conditions associated with venous insufficiency and vasculitis. Notably, a meta-analysis has confirmed that phlebotonics, including ruscogenins, significantly alleviate symptoms related to hemorrhoidal disease, indicating a strong clinical significance despite limited effect sizes reported for ruscogenin alone.

How it works

Ruscogenins improve venous tone, enhance lymphatic drainage, and decrease capillary permeability via multiple biological pathways. They exert anti-inflammatory and antithrombotic effects by modulating interactions with muscarinic receptors, specifically the M1 and M3 subtypes. This receptor engagement contributes to their vasoprotective properties, aiding in the reduction of inflammation and thrombosis within the vascular system.

Side effects

Ruscogenins are generally regarded as safe when utilized at recommended dosages. While specific side effects related to ruscogenins alone are not well-documented, combinations involving diosmin and hesperidin have exhibited a mild side effect profile, with gastrointestinal disturbances and rare allergic reactions being reported in less than 5% of users. Severe side effects are infrequent. Caution is advised when coadministering with anticoagulants due to their antithrombotic properties. Contraindications include use during pregnancy and breastfeeding due to insufficient safety data, as well as caution in patients with active bleeding or severe vascular conditions. Individuals with liver or kidney diseases should seek medical supervision when using ruscogenins.

Dosage

The typical dosage of ruscogenins is 100 mg per day, often utilized in combination with diosmin (500 mg) and hesperidin (90 mg) for enhanced efficacy against hemorrhoidal disease. There is no specific established maximum safe dose for ruscogenins alone, although dosages in combination therapy are generally tolerated without adverse effects. A 30-day treatment regimen is recommended for satisfactory results, with oral administration being the most common method. Absorption is generally favorable when taken as part of a phlebotonic regimen.

FAQs

How long does it take to see benefits?

Benefits are typically observed within a 30-day treatment period.

Are there any interactions with other medications?

Caution should be exercised with anticoagulant medications due to potential interactions.

Can it be used during pregnancy or breastfeeding?

There is insufficient data to recommend use during pregnancy and breastfeeding.

What kind of results can be expected?

Ruscogenins can significantly improve symptoms of hemorrhoidal disease, such as bleeding and pain.

Is ruscogenin a cure for hemorrhoidal disease?

No, ruscogenins are not a cure but can significantly alleviate symptoms.

Research Sources

https://journals.lww.com/fjs/fulltext/2022/55040/a_combination_of_diosmin,_hesperidin,_and.1.aspx?WT.mc_id=HPxADx20100319xMP – This observational study demonstrated the effectiveness of a combination therapy involving diosmin, hesperidin, and ruscogenin in treating symptomatic hemorrhoidal disease. Significant improvements in symptoms were noted over a 30-day duration, supporting the safety and efficacy of this treatment regimen.
https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2023.1126110/full – This meta-analysis explored multiple studies focusing on the efficacy of phlebotonics, including ruscogenins, finding statistically significant reductions in bleeding, pain, and other symptoms associated with hemorrhoidal conditions.
https://www.researchgate.net/publication/9012833_Meta-analysis_of_clinical_trials_of_Cyclo_3_Fort_in_the_treatment_of_chronic_venous_insufficiency – Although not focused solely on ruscogenins, this meta-analysis addresses the efficacy of phlebotonics, underscoring the need for rigorous methodologies in evaluating their use in chronic venous insufficiency treatment.